Connect public, paid and private patent data with Google Patents Public Datasets

Occult blood testing apparatus with features for enhancing ease of use

Download PDF

Info

Publication number
US20070116593A1
US20070116593A1 US11654067 US65406707A US2007116593A1 US 20070116593 A1 US20070116593 A1 US 20070116593A1 US 11654067 US11654067 US 11654067 US 65406707 A US65406707 A US 65406707A US 2007116593 A1 US2007116593 A1 US 2007116593A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
specimen
test
applicator
housing
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11654067
Inventor
Burrell Clawson
Original Assignee
Diagnostica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0038Devices for taking faeces samples; Faecal examination devices

Abstract

A self-contained system for testing for the presence of occult blood in a specimen has been provided with features enhancing its ease of use. The system includes a housing holding a test matrix and a container for releasing a developing medium onto the test matrix. The housing includes a base portion encasing both the container and the test matrix, and a moveable cover for selectively covering and uncovering the base. The cover is provided with a tab which can be manipulated with a finger of one hand, and the base is provided with tabs which can be grasped easily with one or two other fingers of the same hand, thus allowing the cover to be easily opened and closed with one hand. Other ease-of-use features include an applicator with a tip configured for optimized retrieval and even spreading of the specimen on the test matrix, and indicia imprinted at various positions on the housing designating both the location and order in which the different steps of the testing procedure are to be performed

Description

    RELATED APPLICATION
  • [0001]
    This is a divisional of U.S. patent application Ser. No. 10/139,473 filed on May 3, 2002, the entire disclosure of which is incorporated herein.
  • BACKGROUND OF THE INVENTION
  • [0002]
    The present invention is directed to systems and methods useful in testing for occult blood in a fecal specimen. More particularly, the invention is directed to a testing apparatus which is suitable for at-home use by untrained individuals, as well as by clinicians in hospitals and doctor offices.
  • [0003]
    Over 140,000 new persons per year in the United States are afflicted with cancer of the colon and rectum, the disease occurring equally in both men and women. Contrary to many other forms of cancer, early diagnosis and treatment of colorectal cancer and its precursor polyps does result in a cure rate of 80% to 90%. If, however, the disease is not detected until the later stages, the cure rate drops significantly. Thus, early detection of the disease is important to successful treatment of colorectal cancer. For this reason, it is recommended that all individuals over age 50 with no family history of the disease be screened annually for colorectal cancers. Individuals with family history of the disease or other known risk factors should be screened annually beginning no later than age 40.
  • [0004]
    Conventional screening procedures consist of testing for occult (hidden) blood in stool samples provided by a patient. Typically, the patient must collect two separate specimens on a test card on each of three consecutive days, and then deliver the test cards to a laboratory. At the laboratory, a physician or lab technician applies developer liquid to each specimen's test matrix, which has previously been impregnated with a suitable chromogenic reagent, such as guaiac. If blood is present in the specimen, the chromogenic reagent will cause the test matrix to change colors when the developer fluid is added, indicating that fecal occult blood or a similar reactant has been found.
  • [0005]
    One factor deterring individuals from undergoing their recommended annual screening is the natural revulsion which many, if not most, people feel toward handling and looking at fecal matter. This revulsion may be amplified by the lack of a suitable implement for obtaining a specimen and applying it to the test matrix. Most test kits simply provide a wooden coffee-stirrer type stick which is somewhat difficult to manipulate and often, because of its generally smooth exterior surface, does not pick up a large enough sample or retain the sample without risk of dropping some of the fecal matter. Another unpleasant factor is the inconvenience and, sometimes, embarrassment associated with transporting or mailing the fecal matter specimens to a testing laboratory in a paper envelope.
  • [0006]
    In order to eliminate or reduce the aforementioned problems, various attempts have been made to develop a convenient test kit which requires a minimum of handling of fecal specimens, and can be performed by an untrained individual in the privacy of his or her own home. Examples of such attempts are disclosed in U.S. Pat. Nos. 4,582,685 and 5,196,167 to Guadagno et al., and U.S. Pat. No. 5,840,584 to Waldenburg. None of these prior art test kits have successfully met all of the needs of in-home users, however, and none has been approved by the FDA for over-the-counter sale.
  • [0007]
    To date, the only fecal occult blood testing kit which has been approved by for the FDA for over-the-counter sale is a kit manufactured by Diagnostica, Inc., of Las Vegas, Nev., features of which are disclosed in U.S. patent application Ser. No. 09/132,439 and International Application No. PCT/US99/17954. The Diagnostica kit comprises a container of free-standing developing medium, and a test matrix having a specimen placement area on one side. On the opposite side of the test matrix is a result area that generally coincides with the specimen placement area, and a control area that is longitudinally spaced from the result area. Both the container and the matrix are encased in a housing having a first pair of openings aligned with the specimen placement area, a second pair of openings aligned with the result area, and a third pair of openings aligned with the control area. A cover is provided for securely enclosing a specimen located on the specimen placement area. To test for occult blood, a user simply places fecal specimens in the openings aligned with the specimen placement area, closes the cover, compresses the housing to break the container and releases the developing medium. He or she then turns the housing over to look for appropriate color changes in the result and control areas.
  • [0008]
    The aforementioned Diagnostica test kit possesses numerous advantages over the prior art. The cover is particularly advantageous, since it keeps the fecal specimen out of the user's sight and prevents it from dropping off of leaking from the specimen placement area, even when the user inverts the housing to read the results. In addition, the kit can be disposed of easily and hygienically after testing, with no need for special handling.
  • [0009]
    Nonetheless, the Diagnostica kit disclosed in the aforementioned U.S. and International patent applications has some potential drawbacks. Users who have not performed the test before may have difficulty understanding or remembering the instructions and may perform the steps in the wrong order. In addition, some users may collect too little or too much sample on the stick provided with the kit, and have difficulty spreading it over the specimen placement area. Still others may find it difficult to open and close the cover of the housing with one hand while holding the specimen collection stick in the other hand.
  • [0010]
    Accordingly, it would be advantageous to provide an apparatus for testing for occult blood, for example, fecal occult blood, with features that enhance its ease of use by untrained individuals. Further, it would be advantageous to provide a hygienic and relatively simple test kit which reduces the need for manual dexterity, while providing accurate and reliable results.
  • SUMMARY OF THE INVENTION
  • [0011]
    A self-contained system for testing for the presence of occult blood in a specimen has been provided with features enhancing its ease of use. The system includes a housing holding a test matrix and a container for releasing a developing medium onto the test matrix. The housing includes a base portion encasing both the container and the test matrix, and a moveable cover for selectively covering and uncovering the base. The cover is provided with a tab which can be manipulated with a finger of one hand, and the base is provided with tabs which can be grasped easily with one or two other fingers of the same hand, thus allowing the cover to be easily opened and closed with one hand.
  • [0012]
    An applicator provided for use with the system includes a handle portion configured to be grasped by a user and a distal portion having an end configured for optimized retrieval and spreading of the specimen on the test matrix. In a preferred embodiment, the applicator comprises two identical applicator halves, one of which serves as the handle portion and the other of which serves as the distal portion. Connector elements are provided for joining the two halves together. For reasons of manufacturing convenience, the two halves are integrally formed with and frangibly connected to opposite sides of the system housing. To use the applicator, a user simply detaches the two applicator halves from the housing, assembles them end-to-end, then collects and applies the specimen as instructed.
  • [0013]
    The instructions for use are preferably embossed or otherwise printed on the various components of the system. These instructions preferably indicate both the order in which the steps of the testing procedure are to be performed, and the location for carrying out the steps. Thus, steps to be performed with the cover closed are provided on the cover, steps to be performed with the cover open are provided on the top portion of the base, and steps to be performed with the housing inverted (and the cover closed) are provided on the bottom portion of the base. This reduces the chance of any confusion on the part of the user, and increases the likelihood that the test will be performed correctly and accurate results obtained.
  • [0014]
    Each and every feature and combination of two or more features described herein is included within the scope of the present invention provided that the features included in the combination are not mutually inconsistent.
  • [0015]
    These and other aspects and advantages of the present invention are set forth in the following detailed description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0016]
    FIG. 1 is a perspective view of a system for testing for fecal occult blood in accordance with the present invention, with a portion broken away to show interior detail;
  • [0017]
    FIG. 2 is a plan view of the housing, cover, and applicator of the system before assembly;
  • [0018]
    FIG. 2A is an enlarged end view of the bottom section of the housing before assembly;
  • [0019]
    FIG. 3 is a plan view of the system after assembly;
  • [0020]
    FIG. 4 is an enlarged fragmentary perspective view showing a portion of the base of the system housing, with a portion broken away to show interior detail;
  • [0021]
    FIG. 5 is a perspective view of an applicator assembly in accordance with the present invention;
  • [0022]
    FIG. 6 is an enlarged plan view of the encircled area 6-6 of FIG. 5;
  • [0023]
    FIG. 7 is a plan view of the encircled area 7-7 of FIG. 5;
  • [0024]
    FIG. 8 is an enlarged, fragmentary view of a section taken through line 8-8 of FIG. 1;
  • [0025]
    FIG. 9 is an enlarged end view of FIG. 7;
  • [0026]
    FIG. 10 is a top plan view of the housing of the system according to a preferred embodiment, with the cover in a closed position;
  • [0027]
    FIG. 11 is a perspective view of the housing according to the embodiment shown in FIG. 10, with the cover in an open position; and
  • [0028]
    FIG. 12 is a bottom plan view of the housing according to the embodiment of FIG. 10.
  • DETAILED DESCRIPTION OF THE DRAWINGS
  • [0029]
    Referring now to the drawings, FIG. 1 shows a self-contained system 10 for testing for a reactant such as occult blood in a specimen of a spreadable substance such as fecal matter (not shown). The system comprises a housing 12 enclosing a test matrix 14 such as guaiac-treated paper (shown in FIG. 4), and a glass ampule 16 filled with a free-standing liquid developing medium such as liquid hydrogen peroxide/ethyl alcohol solution. An applicator 18 is provided for collecting the fecal matter specimen and applying it to a specimen placement area 20 on the test matrix 14.
  • [0030]
    Referring now to FIG. 2, the unassembled housing, which is preferably provided to the consumer in a hermetically sealed foil pouch (not shown), includes a base 22 and a cover 24. The base 22 has a bottom section 26 and a top section 28. Identical applicator halves 30 and 32 are coupled to opposite sides of the top section 28 of the base 22. In a preferred embodiment of the invention, the cover 24, bottom section 26, top section 28, and applicator halves 30, 32 are made from a unitary or single piece of plastic or polymer material. The cover 24, bottom base section 26, and top base section 28 are preferably flexibly and serially joined to one another by thinned hinge elements 34 and 36, while the applicator halves 30, 32 are frangibly connected to the top section 28 of the base 22 by weakened elements 38, 39, 40, and 41. Other embodiments of the invention may provide the applicator separately from the housing, for example, and/or in a single piece, as a pair of non-identical pieces or more than two pieces. Similarly, the cover and the sections of the base could be made of more than one piece, made of materials other than plastic, and/or have sections of other shapes.
  • [0031]
    FIG. 3 shows the system 10 in the form in which it is provided to the user. The test matrix and ampule have been placed underneath the top section 28 of the base 22, and the bottom section 26 has been folded up against the top section 28, locking the test matrix and ampule into position. The cover 24 has been latched over the specimen placement openings to prevent contamination of the test matrix during transport. The only portion of the system 10 which has not been preassembled is the applicator 18.
  • [0032]
    Returning now to FIG. 2 with additional reference to FIG. 12, the bottom section 26 of the base 22 has two oblong openings 42, 44 near a first end 46. The oblong openings have beveled edges 48 for better viewing of the validation areas 50 of the test matrix 14. Two rectangular openings 52, 54 are provided near a second end 56 of the bottom section 26. The rectangular openings 52, 54 have beveled edges 58 for better viewing of the result areas 60 of the test matrix 14. A circular depression 62 is located in the second surface 51 intermediate the validation area viewing openings 42, 44 and the result area viewing openings 52, 54. A protuberance 64 is located in the center of the depression 62. The depression 62 decreases the rigidity of the bottom section 26 and enables a user to compress the ampule when the protuberance 64 is pressed against a hard, flat surface such as a table or counter top.
  • [0033]
    It has been found that a depression 62 formed in the second surface 51 of the bottom section 26 reduces the amount of liquid needed to saturate the matrix relative to the amount that would be needed if the depression were formed in the first surface 49.
  • [0034]
    FIG. 2A is an enlarged end view showing that the bottom section 26 of the base is slightly curved about a vertical axis of symmetry y. Specifically, the bottom section 26 has generally flat side edge portions 43, 45, and a central portion 47 including a first surface 49 and a second surface 51, both of which are somewhat concave with respect to the illustrated horizontal axis x. When the bottom section 26 is folded about the front hinge 36 and snapped into place underneath the top section 28, the curvature is flattened with respect to the horizontal axis x. Thus, the first surface 49 is urged against the center of the top section, compressing the test matrix and holding it securely in place. This minimizes the amount of open space between the top and bottom sections 26 and 28, which in turn further minimizes the amount of liquid needed to saturate the matrix in a given short period of time.
  • [0035]
    The top section 28 of the base 22, best shown in FIG. 11, includes two rectangular openings 66, 68 that align with specimen placement areas 70 on the text matrix 14, on the opposite side from the result areas 60 and result viewing openings 52, 54. An oblong ampule-holding dome 74 extends between the specimen placement openings 66, 68 and the end of the top section 28 near the rear hinge 34. Extending from the inner top wall of the dome 74 are two projections (not shown) which act in tandem with the depression 62 and protuberance 64 on the bottom section 26 to facilitate breaking of the ampule 16.
  • [0036]
    The front hinge 36 projects distally along the front of the section 28 and matingly receives a hook 75 depending from the underside of the cover 24 to latch the cover when necessary. A gripping arrangement comprising tabs 77, 79 and 81 (seen in FIG. 10) is provided for allowing a user to easily open and close the cover 24 with one hand while holding an applicator in the other hand. Specifically, the tabs 77, 79, which extend distally and laterally from the corners of the top section 28 on either side of the hinge 36, are structured for a user to hold between two fingers, for instance the thumb and middle finger, of one hand while pressing upwardly with another finger, for instance the index finger, of the same hand against the tab 81 extending distally from the front edge of the cover 24. Strictly speaking, only one tab 77 or 79 is required on the top section 28 of the base, since most users will be able to open the cover 24 using only the thumb and finger of one hand. However, two tabs 77, 79 are preferred, since such an arrangement is equally convenient for both right and left-handed users, and also for users with decreased manual dexterity or strength.
  • [0037]
    Referring again to FIG. 3, with additional reference to FIGS. 5 and 6, each of the applicator halves 30, 32 comprises a relatively narrow distal end 76 a,b and a wider, hollow proximal end 78 a,b. To assemble the applicator 10, the user simply detaches the two applicator halves 30, 32 from the sides of the base 28, and inserts the distal end 76 b of one applicator half 32 into the hollow proximal end 78 a of the other applicator half 30. A close fit between the distal end 76 b of one applicator half 32 and the receiving proximal end 78 a of the other applicator half 30 ensures that the halves 30, 32 will be securely joined.
  • [0038]
    When the applicator halves 30, 32 are assembled, the proximally positioned half 32 serves as a handle to be grasped by the user, while the distal end 76 a of the distally positioned half 30 serves as a collector and spreader.
  • [0039]
    Referring now to FIGS. 7-9, the spreader or distal end 76 a of the applicator 18 includes a generally planar front surface 80, a generally planar rear surface (not shown) and a pair of side walls 82, 84. The front and rear surfaces are recessed with respect to the side walls 82, 84, and intersect to form a shoulder 86 that curves about a center of curvature x′ to define a first radius of curvature R. A spreading tip 88 extends distally of the shoulder 86.
  • [0040]
    The features of the spreading tip 88 can best be appreciated after considering the design of the specimen placement openings, as shown in detail in FIGS. 4 and 8. Specifically, the specimen placement openings 66, 68 have beveled, generally trapezoidal walls 72 that assist in positioning specimens on the specimen placement area 70 and define a recess with enough volume to receive and hold a fecal sample when the cover 24 is closed. Each recess has a width w equal to the width of the specimen placement area and a depth d equal to the height of the beveled walls 72. The spreading tip 88 includes a pair of side edges 92, 93 which are preferably conical and have a cone angle conforming to the beveled side walls 72 of the specimen placement openings 66, 68. In the most preferred embodiment of the invention, the width w of the distal surface 90 is substantially equal to the width w of the specimen placement openings 66, 68, and the length L of the spreading tip 88 is slightly less than the depth d of the specimen placement openings 66, 68. This close fit between the tip 88 and the specimen placement openings 66, 68 helps ensure that the applicator tip spreads the specimen evenly and thinly over the specimen placement area.
  • [0041]
    In addition, the spreading tip has a curved distal surface 90 that extends between the side edges 92, 93. The distal surface 90 defines a second radius of curvature r=R+L about the center of curvature x′. Because the spreading tip 88 and the end portion 85 of the applicator have the same center of curvature x′, a user is able to maintain a constant distance from the center x′ to the test matrix while applying the samples, regardless of moderate changes of the angle at which the applicator 18 is tilted with respect to the test matrix. This results in a constant clearance c between the distal surface 90 of the applicator and the test matrix 14, allowing the user to easily apply the specimen in a layer of fairly uniform thickness.
  • [0042]
    The distal and proximal surfaces 90, 91 of the spreading tip 88 are preferably textured or otherwise enhanced to increase the amount of fecal matter collected by the applicator 18 and minimize the likelihood of any fecal matter falling off. In the illustrated embodiment, best seen in FIG. 9, the textured surface 90 comprises a multitude of small bumps yielding a sandpaper-like finish. Other surface features, such as grooves, fins, dimples or the like, that increase the effective surface area and holding power of the tip can also be used. Alternatively, the retentiveness of the surface could be enhanced with coatings having adhesive properties or an affinity for fecal matter.
  • [0043]
    FIGS. 10-12 show an especially preferred embodiment of the invention, wherein the various components of the housing 12 include indicia leading the user through the steps of a testing procedure. The indicia are preferably provided in sets, with each set of indicia designating both the order in which a particular step is to be performed, and the place for performing it. For instance, a first set of indicia 94 provided near the distal end of the cover 24 of the housing 12 may point toward the tab 81 and instruct the user to “LIFT FIRST.” Upon lifting the cover, the user may find a second set of indicia 95 near the specimen placement openings 66, 68, instructing him or her to (apply the) “SAMPLES 2nd.” A third set of indicia 96 located on the cover 24 on an upper dome 97 above the ampule-holding dome 74 may instruct the user to “PRESS 3rd”, thus breaking the capsule and releasing the developing medium onto the test matrix. A fourth set of indicia 98 on the bottom section 26 of the housing base 22 identifies the location of the “CONTROLS” and “RESULTS” and instructs the user that these are to be viewed “4th.”
  • [0044]
    For optimum readability, it is preferred that the indicia be embossed on the housing. However, imprinted stickers or other less permanent forms of indicia may be preferable in some instances, especially in overseas markets where many languages will be required. Additional indicia could be provided for designating where to snap the applicator halves off the housing, indicating which end of the applicator is the sample end, warning the user not to open the base because of glass inside, and so forth. Of course, the exact wording of any of the instructions is not critical, and may be varied according to consumer needs.
  • [0045]
    The indicia may also provide information such as a website, mailing address, or phone number which the user may contact if he or she has questions about the procedure or results. If the results are positive or indeterminate, the user may wish to save another undeveloped test kit to show to a physician. Ideally, if the results are clearly negative, the user simply reinserts the kit and applicator halves into the foil pouch in which they were provided, folds over the top of the pouch, and throws it away. No further special handling or sanitary precautions are needed since the fecal matter is entirely enclosed.
  • [0046]
    While this invention has been described with respect to various specific examples and embodiments, it is to be understood that the invention is not limited thereto and that it can be variously practiced within the scope of the following claims. For instance, the ease of use features disclosed can successfully be used with fecal blood testing kits employing polyclonal or monoclonal antibody systems, or any other alternatives to the guaiac-based chemistry system disclosed in International Patent Application No. PCT/US99/17594. The features may also be used in both chemical and non-chemical systems for revealing the presence of a wider variety of anomalous substances other than blood, such as parasites, for instance, in feces or other spreadable specimens.

Claims (29)

1. An applicator for collecting a spreadable specimen and spreading the specimen on a test matrix, the applicator comprising:
a handle portion configured to be grasped by a user; and
a distal portion including a distal tip having conical side edges and a distal tip surface between the conical side edges and configured for optimized collection and spreading of the specimen on the test matrix.
2. (canceled)
3. (canceled)
4. The applicator according to claim 1 wherein:
the distal portion includes a shoulder portion extending beyond the distal tip conical side edges.
5. (canceled)
6. The applicator according to claim 1, wherein the distal tip surface is textured.
7. The applicator according to claim 1, further comprising at least one coupling element on at least one of the handle portion and the distal portion for coupling the distal portion to the handle portion.
8. The applicator according to claim 1 wherein the handle portion and the distal portion are substantially identical in size and form and are configured to be engageable with one another.
9. A system for testing for the presence of an anomalous substance in a specimen, the system comprising:
a test matrix having a specimen placement area on one side;
a housing holding the test matrix, the housing including a base and a moveable lid couplable with the base and structured and positionable between an open position exposing the specimen placement area and a closed position covering the specimen placement area;
the housing structured such that the lid can be single-handedly manipulated between the open position and the closed position.
10. (canceled)
11. The system according to claim 9, wherein the housing further comprises a grip region extending from the base.
12. The system according to claim 11, wherein the grip region comprises two tabs extending from opposite corners of an edge of the base.
13. The system according to claim 11 wherein
the housing is configured to be conveniently held in one hand; and
the housing further comprises at least one tab extending from the lid and configured to be manipulated by one finger of a human hand while the grip region is grasped by at least one other finger of the hand.
14. The system according to claim 9, wherein:
the housing is configured to be conveniently held in one hand; and
the housing further comprises at least one tab extending from the lid and configured to be manipulated by the index finger of a human hand and two tabs extending from the base and configured to be simultaneously manipulated by the thumb and another finger of the hand.
15. (canceled)
16. (canceled)
17. (canceled)
18. A self-contained system for testing for the presence of an anomalous substance in a specimen, the system comprising:
a test matrix having a specimen placement area on one side;
a housing holding the test matrix, the housing including a base having an opening aligned with the specimen placement area of the test matrix and a moveable lid engageable with the base and structured and positionable between an open position exposing the specimen placement area and a closed position covering the specimen placement area; and
instructions on the housing indicating an order in which a series of steps to is to be performed during testing for the presence of an anomalous substance in a specimen.
19. The self-contained system according to claim 18, wherein the instructions comprise a plurality of indicia sets, wherein each indicia set corresponds to a different step in the series and is located at a place on the housing where the corresponding step is to be performed.
20. The self-contained system according to claim 18, wherein:
the housing comprises a base portion having an opening aligned with the specimen placement area, and a cover mounted for movement between an open position exposing the specimen placement area and a closed position covering the specimen placement area; and
the instructions include at least one indicia set on the cover for designating at least one step to be carried out with the cover closed, and at least one indicia set on the base for designating at least one step to be carried out with the cover open.
21. (canceled)
22. The self-contained system according to claim 18, wherein the system further includes a container holding a developing medium, wherein the container is encased by the housing and positioned and structured to be broken to release the developing medium onto the test matrix.
23. The self-contained system according to claim 22, wherein the instructions include at least one indicia set on the housing aligned with the container for indicating when, where, and how to break the container.
24. The self contained system according to claim 18 further comprising an applicator structured to facilitate application of a spreadable specimen to the specimen placement area, the applicator including
a handle portion configured to be grasped by a user,
a distal portion including a distal tip configured for collecting and spreading a specimen on the test matrix, and
at least one coupling element on at least one of the handle portion and the distal portion for securing the handle portion to the distal portion.
25-30. (canceled)
31. The self-contained system according to claim 18 further comprising
an applicator having a distal end for applying a spreadable specimen onto the specimen placement area, the applicator having a configuration enabling mating engagement of the applicator distal end with the opening for promoting uniform application of a spreadable specimen applied to the specimen placement area.
32. The self-contained system according to claim 31 wherein the distal end of the applicator is configured to maintain a clearance between the distal tip and the test matrix when the applicator is matingly engaged with the opening.
33. The self-contained system according to claim 31 wherein the distal tip includes conical side edges.
34. The self-contained system according to claim 33 wherein the distal portion includes a shoulder portion extending beyond the distal tip conical side edges.
US11654067 2002-05-03 2007-01-16 Occult blood testing apparatus with features for enhancing ease of use Abandoned US20070116593A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10139473 US7189356B1 (en) 2002-05-03 2002-05-03 Occult blood testing apparatus with features for enhancing ease of use
US11654067 US20070116593A1 (en) 2002-05-03 2007-01-16 Occult blood testing apparatus with features for enhancing ease of use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11654067 US20070116593A1 (en) 2002-05-03 2007-01-16 Occult blood testing apparatus with features for enhancing ease of use

Publications (1)

Publication Number Publication Date
US20070116593A1 true true US20070116593A1 (en) 2007-05-24

Family

ID=37833358

Family Applications (2)

Application Number Title Priority Date Filing Date
US10139473 Active 2023-02-14 US7189356B1 (en) 2002-05-03 2002-05-03 Occult blood testing apparatus with features for enhancing ease of use
US11654067 Abandoned US20070116593A1 (en) 2002-05-03 2007-01-16 Occult blood testing apparatus with features for enhancing ease of use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10139473 Active 2023-02-14 US7189356B1 (en) 2002-05-03 2002-05-03 Occult blood testing apparatus with features for enhancing ease of use

Country Status (1)

Country Link
US (2) US7189356B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080131971A1 (en) * 2006-09-25 2008-06-05 Diagnostica, Inc. Occult blood testing device

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488450B2 (en) * 2004-03-04 2009-02-10 Beckman Coulter, Inc. Analyte collection and detection devices
US8679420B2 (en) * 2004-07-22 2014-03-25 Immunostics, Inc. Fecal sampling device and method
US20080241940A1 (en) * 2004-07-22 2008-10-02 Lastella Vincent P Fecal sampling device and method
US7556769B2 (en) * 2006-11-10 2009-07-07 Kevin Kikta Fecal occult test packaging
US8304596B2 (en) 2008-04-11 2012-11-06 Immunostics, Inc. Fecal sampling device and method

Citations (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281903A (en) * 1883-07-24 James mckenzie
US4071317A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances and process for preparing same
US4337734A (en) * 1979-09-27 1982-07-06 Yamaha Hatsudoki Kabushiki Kaisha Two-cycle engine
US4365970A (en) * 1981-05-01 1982-12-28 Smithkline Instruments, Inc. Specimen test slide and method for testing occult blood
US4382064A (en) * 1981-01-29 1983-05-03 Smithkline Instruments, Inc. Specimen slide for occult blood testing
US4562043A (en) * 1983-09-09 1985-12-31 Mennen Frederick C Self-contained swab cartridge apparatus for detecting occult blood
US4582685A (en) * 1982-10-07 1986-04-15 Helena Laboratories Corporation Test kit for performing a medical test
US4615982A (en) * 1984-12-11 1986-10-07 Lawrence Paul J Fecal occult blood test
US4645743A (en) * 1986-03-11 1987-02-24 Smithkline Diagnostics, Inc. Method and device for collecting and testing for fecal occult blood
US4738823A (en) * 1985-08-30 1988-04-19 Miles Laboratories, Inc. Test strip with adjustable sample absorption capacity
US4789629A (en) * 1986-11-24 1988-12-06 Smithkline Beckman Corporation Method and device for collecting and testing for fecal occult blood
US4818702A (en) * 1986-06-02 1989-04-04 Litmus Concepts, Inc. Fecal occult blood test reagent
US4937197A (en) * 1984-12-11 1990-06-26 Litmus Concepts, Inc. Fecal occult blood test method
US4939097A (en) * 1986-06-02 1990-07-03 Litmus Concepts, Inc. Fecal occult blood test methods
US4983416A (en) * 1985-02-04 1991-01-08 Propper Manufacturing Co., Inc. Manufacturing method for an occult fecal blood test slide
US5100619A (en) * 1989-05-09 1992-03-31 Beckman Instruments, Inc. Device and method for collecting fecal occult blood specimens
US5106582A (en) * 1990-12-18 1992-04-21 Smithkline Diagnostics, Inc. Specimen test slide and method of testing for fecal occult blood
US5137808A (en) * 1987-04-07 1992-08-11 Syntex (U.S.A.) Inc. Immunoassay device
US5171629A (en) * 1989-01-17 1992-12-15 Hoechst Aktiengesellschaft Flame-resistant carrier web for bitumen webs and a process for its production
US5182191A (en) * 1988-10-14 1993-01-26 Pacific Biotech, Inc. Occult blood sampling device and assay
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5198365A (en) * 1987-02-04 1993-03-30 International Immunoassay Laboratories, Inc. Fecal sample immunoassay method testing for hemoglobin
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5254181A (en) * 1989-06-10 1993-10-19 Daidousanso Co., Ltd. Method of nitriding steel utilizing fluoriding
US5310680A (en) * 1987-09-16 1994-05-10 Smithkline Diagnostics, Inc. Test for fecal occult blood
US5344762A (en) * 1992-03-29 1994-09-06 Era-Masis, Ltd. Method for the early diagnosis of cancer
US5391498A (en) * 1987-09-16 1995-02-21 Smithkline Diagnostics, Inc. Test for fecal occult blood
US5504013A (en) * 1993-11-12 1996-04-02 Unipath Limited Analytical devices and methods of use thereof
US5593851A (en) * 1994-04-01 1997-01-14 Chek-Med Systems, Inc. Test kid for the rapid detection of helicobacter pylori in gastric biopsy tissue
US5747351A (en) * 1995-06-07 1998-05-05 Smithkline Diagnostics, Inc. Immunochemical-based test device with lift and twist specimen full tab
US5840584A (en) * 1995-06-07 1998-11-24 Waldenburg; Ottfried Blood in feces test device
US6077711A (en) * 1998-02-25 2000-06-20 Singer; Jason Frangible ampule specimen test card
US6436714B1 (en) * 1998-08-11 2002-08-20 Diagnostica, Inc. Self-contained system and method for testing for fecal occult blood

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4333734A (en) 1980-01-18 1982-06-08 Sloan-Kettering Institute For Cancer Research Diagnostic device for fecal occult blood and method of use
US5264181A (en) 1992-01-24 1993-11-23 Robert Schreiber Occult blood testing device
US5171529A (en) 1992-01-24 1992-12-15 Robert Schreiber Occult blood testing device
EP1102840A2 (en) 1998-08-04 2001-05-30 Cor Therapeutics, Inc. Transgenic animals having a modified glycoprotein v gene

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281903A (en) * 1883-07-24 James mckenzie
US4071317A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances and process for preparing same
US4337734A (en) * 1979-09-27 1982-07-06 Yamaha Hatsudoki Kabushiki Kaisha Two-cycle engine
US4382064A (en) * 1981-01-29 1983-05-03 Smithkline Instruments, Inc. Specimen slide for occult blood testing
US4365970A (en) * 1981-05-01 1982-12-28 Smithkline Instruments, Inc. Specimen test slide and method for testing occult blood
US4582685A (en) * 1982-10-07 1986-04-15 Helena Laboratories Corporation Test kit for performing a medical test
US4562043A (en) * 1983-09-09 1985-12-31 Mennen Frederick C Self-contained swab cartridge apparatus for detecting occult blood
US4937197A (en) * 1984-12-11 1990-06-26 Litmus Concepts, Inc. Fecal occult blood test method
US4615982A (en) * 1984-12-11 1986-10-07 Lawrence Paul J Fecal occult blood test
US4983416A (en) * 1985-02-04 1991-01-08 Propper Manufacturing Co., Inc. Manufacturing method for an occult fecal blood test slide
US4738823A (en) * 1985-08-30 1988-04-19 Miles Laboratories, Inc. Test strip with adjustable sample absorption capacity
US4645743A (en) * 1986-03-11 1987-02-24 Smithkline Diagnostics, Inc. Method and device for collecting and testing for fecal occult blood
US4818702A (en) * 1986-06-02 1989-04-04 Litmus Concepts, Inc. Fecal occult blood test reagent
US4939097A (en) * 1986-06-02 1990-07-03 Litmus Concepts, Inc. Fecal occult blood test methods
US4789629A (en) * 1986-11-24 1988-12-06 Smithkline Beckman Corporation Method and device for collecting and testing for fecal occult blood
US5198365A (en) * 1987-02-04 1993-03-30 International Immunoassay Laboratories, Inc. Fecal sample immunoassay method testing for hemoglobin
US5137808A (en) * 1987-04-07 1992-08-11 Syntex (U.S.A.) Inc. Immunoassay device
US5391498A (en) * 1987-09-16 1995-02-21 Smithkline Diagnostics, Inc. Test for fecal occult blood
US5310680A (en) * 1987-09-16 1994-05-10 Smithkline Diagnostics, Inc. Test for fecal occult blood
US5182191A (en) * 1988-10-14 1993-01-26 Pacific Biotech, Inc. Occult blood sampling device and assay
US5171629A (en) * 1989-01-17 1992-12-15 Hoechst Aktiengesellschaft Flame-resistant carrier web for bitumen webs and a process for its production
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5100619A (en) * 1989-05-09 1992-03-31 Beckman Instruments, Inc. Device and method for collecting fecal occult blood specimens
US5254181A (en) * 1989-06-10 1993-10-19 Daidousanso Co., Ltd. Method of nitriding steel utilizing fluoriding
US5106582A (en) * 1990-12-18 1992-04-21 Smithkline Diagnostics, Inc. Specimen test slide and method of testing for fecal occult blood
US5344762A (en) * 1992-03-29 1994-09-06 Era-Masis, Ltd. Method for the early diagnosis of cancer
US5504013A (en) * 1993-11-12 1996-04-02 Unipath Limited Analytical devices and methods of use thereof
US5504013B1 (en) * 1993-11-12 2000-03-14 Unipath Ltd Analytical devices and methods of use thereof
US5593851A (en) * 1994-04-01 1997-01-14 Chek-Med Systems, Inc. Test kid for the rapid detection of helicobacter pylori in gastric biopsy tissue
US5668011A (en) * 1994-04-01 1997-09-16 Chek-Med Systems, Inc. Molded pick for handling biopsy specimens
US5747351A (en) * 1995-06-07 1998-05-05 Smithkline Diagnostics, Inc. Immunochemical-based test device with lift and twist specimen full tab
US5840584A (en) * 1995-06-07 1998-11-24 Waldenburg; Ottfried Blood in feces test device
US6077711A (en) * 1998-02-25 2000-06-20 Singer; Jason Frangible ampule specimen test card
US6436714B1 (en) * 1998-08-11 2002-08-20 Diagnostica, Inc. Self-contained system and method for testing for fecal occult blood

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080131971A1 (en) * 2006-09-25 2008-06-05 Diagnostica, Inc. Occult blood testing device
WO2008039384A3 (en) * 2006-09-25 2009-02-12 Burrell E Clawson Occult blood testing device
US7592181B2 (en) * 2006-09-25 2009-09-22 Diagnostica, Inc. Occult blood testing device

Also Published As

Publication number Publication date Type
US7189356B1 (en) 2007-03-13 grant

Similar Documents

Publication Publication Date Title
US5910122A (en) Saliva collector with an aspirating pipette
US6033914A (en) Electrochemical analytical cartridge
US6303081B1 (en) Device for collection and assay of oral fluids
US7008799B1 (en) Analytical test element with a capillary channel
US5104619A (en) Disposable diagnostic system
US5714123A (en) Protective shield for a blood glucose strip
US6207000B1 (en) Process for the production of analytical devices
US5268148A (en) Saliva sampling device and sample adequacy system
US20040116829A1 (en) Sampling devices and methods utilizing a horizontal capillary test strip
US6180062B1 (en) Device for analyzing a sample
US20040184954A1 (en) Lateral flow immunoassay devices for testing saliva and other liquid samples and methods of use of same
US5100619A (en) Device and method for collecting fecal occult blood specimens
US6379317B1 (en) Analytical measuring device with lancing device
US20070078358A1 (en) Devices and methods for facilitating fluid transport
US4804518A (en) Device for occult blood testing
US4900663A (en) Test kit for determining the presence of organic materials and method of utilizing same
US5954369A (en) Greeting card with kit for health testing
US4473079A (en) Simple, small, self-contained tests for occult blood
US6010462A (en) Blister style culture transport device and method for using the same
US5204063A (en) Eluent release system and automated assay device
US4751751A (en) Disposable urinating funnel for females
US20040173488A1 (en) Disposal device for sampling materials
US20050106750A1 (en) Sample collection cup with integrated sample analysis system
US5916176A (en) Estrogen or estradiol need determination by vaginal or urethral acidity determination
US20030224523A1 (en) Cartridge arrangement, fluid analyzer arrangement, and methods

Legal Events

Date Code Title Description
AS Assignment

Owner name: DIAGNOSTICA CORPORATION, NEVADA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME FROM DIAGNOSTICA, INC. TO DIAGNOSTICA CORPORATION PREVIOUSLY RECORDED ON REEL 012878 FRAME 0329. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT;ASSIGNOR:CLAWSON, BURRELL E.;REEL/FRAME:027119/0691

Effective date: 20020503

AS Assignment

Owner name: CLAWSON, BURRELL E., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAGNOSTICA CORPORATION;REEL/FRAME:027390/0895

Effective date: 20111208

Owner name: MOSS, STEVEN, RHODE ISLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DIAGNOSTICA CORPORATION;REEL/FRAME:027390/0895

Effective date: 20111208